Photocure ASA (OSL: PHO)

Norway flag Norway · Delayed Price · Currency is NOK
55.70
+1.60 (2.96%)
Aug 30, 2024, 4:25 PM CET
27.31%
Market Cap 1.51B
Revenue (ttm) 513.58M
Net Income (ttm) 12.84M
Shares Out 27.11M
EPS (ttm) 0.47
PE Ratio 118.39
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 259,946
Open 54.30
Previous Close 54.10
Day's Range 53.00 - 56.70
52-Week Range 41.70 - 71.90
Beta 1.00
Analysts n/a
Price Target n/a
Earnings Date Aug 30, 2024

About Photocure ASA

Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the BeNeLux, Italy, other European Countries, Canada, and the United States. It operates through Commercial Franchise and Development Portfolio segments. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus-induced cervical p... [Read more]

Sector Healthcare
Founded 1993
Employees 102
Stock Exchange Oslo Børs
Ticker Symbol PHO
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.